Browse stocks · Browse sectors · Healthcare · Healthcare · Pharmaceuticals & Biotechnology · Pharmaceuticals

NSE RESEARCH WORKSPACE

Kopran Ltd

NSE: KOPRAN

OverviewFinancial StatementsQuant ScoreForensic Accounting+

Price1Y

Company Overview

Kopran Ltd is classified in Pharmaceuticals.

Market Cap: ₹ 1,190.27 Cr.
Price in snapshot: ₹ 246.3
ROE: 4.96 %
ROCE: 6.67 %
Dividend Yield: 1.21 %

Snapshot updated 22 July 2026. Figures are not live quotes.

Research coverage

Concall documents: presentation for Q1 FY27, dated 7 August 2026.
Annual-report coverage: FY2026.
Company exchange-filing catalog coverage.

Browse concall documents · Browse exchange filings